American Academy of Family Physicians
About UsNews & PublicationsMembersCME CenterClinical & ResearchPractice MgmtPolicy & AdvocacyCareers

In Midst of Pediatric Hepatitis B Vaccine Shortage, CDC Urges Docs to Not Hoard Doses

Supply Sufficient if Providers Order Wisely, Says Agency

By News Staff
5/19/2009

Supplies of pediatric hepatitis B vaccines are expected to remain tight through the summer, but CDC officials said in a May 5 status update letter (2-page Word file; About Downloading) that supplies will be sufficient through the end of the year, "if providers continue to order vaccine judiciously."
CDC News
Merck and GlaxoSmithKline, or GSK, have been experiencing hepatitis B vaccine supply issues since February. The CDC responded by releasing doses of each manufacturer's monovalent pediatric hepatitis B vaccine from its vaccine stockpiles.

The agency said Merck expects supplies of Recombivax HB, the manufacturer's pediatric hepatitis B vaccine, to be limited through the remainder of 2009, while GSK plans to ship additional supplies of its Pediatric Engerix-B vaccine in the fall.

Providers should continue to administer pediatric hepatitis B vaccine according to the recommended vaccination schedule, (1-page PDF file; About PDFs) said Jeanne Santoli, M.D., M.P.H., acting chief of the Vaccine Supply and Assurance Branch of the Immunization Services Division in the CDC's National Center for Immunization and Respiratory Diseases.

"We are most likely to be successful in maintaining the ability to provide three doses of hepatitis B vaccine to all infants and toddlers on schedule if immunization providers continue routine ordering practices," Santoli said in the letter. "Placing larger-than-normal orders to build a stock of vaccine is discouraged."

Santoli said changes in purchase patterns based on concerns about supply can worsen a shortage.

"Vaccine shortages are frustrating for everyone, but it is important for family physicians to cooperate with the CDC and local health departments and adhere to recommendations regarding ordering and stocking vaccine in order to protect the health of the entire public," said Doug Campos-Outcalt, M.D., M.P.A., the AAFP's liaison to the CDC's Advisory Committee on Immunization Practices and associate head of the department of family and community medicine at the University of Arizona College of Medicine, Phoenix.

Clinical Care & Research

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Pregnant Women

FDA Revises Diabetes Drug Prescribing Information

H1N1 Vaccine Availability Increasing Slowly

ACIP Supports 'Permissive Use' of Gardasil in Males

CDC Survey Shows Overall Gains in Teens' Immunization Rates

FDA Approves Gardasil for Males, Bivalent HPV Vaccine for Girls, Women

New USP Standards for Heparin Decrease Unit Dose Potency

H1N1 Vaccine Deliveries Begin This Week

Clinical Trial of H1N1 in Kids, Teens Shows Mixed Results

Physicians Should Use Caution With Tamiflu Dosages

Prostate Cancer Awareness Campaigns Could Cause Confusion

Federal Health Officials Push H1N1 Vaccine for Adults, Health Workers

IOM: N95 Respirators Offer H1N1 Flu Defense for Health Personnel

CDC Updates Recommendations for Antiviral Use

CDC Updates Guidance on Ophthalmia Neonatorum Prophylaxis

New AHRQ Guides Outline Gestational Diabetes Treatment Options

Erythromycin Ophthalmic Ointment in Short Supply

CDC, FDA Study Reinforces Safety, Efficacy of Gardasil

New GSK Product Should Ease Hib Vaccine Shortage

H1N1 Vaccine Clinical Trials in Adults Free of Adverse Events

AAFP Launches Awareness Campaign for Pertussis Vaccination

H1N1 Vaccine Production Lagging Behind Expectations

FDA Issues Multiple Safety Alerts, Updates

ACIP Updates Poliovirus Vaccination Recommendations

Research Network Seeks Evidence to Support Collaborative Care

Vaccines & Immunizations Special Report

ACIP Issues Targeted Recommendations for H1N1 Vaccinations

CDC Pushes Seasonal Flu Shots for Kids Ages 6 Months to 18 Years